For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb0764Ca&default-theme=true
RNS Number : 0764C GenIP PLC 28 April 2026
28 April 2026
GenIP Plc
("GenIP" or the "Company")
Strategic Resale Alliance with Cardinal Intellectual Property
GenIP Plc (AIM: GNIP), a technology consultancy providing AI-driven services
to help research organisations and corporations commercialise their
innovations, announces a strategic alliance with Cardinal Intellectual
Property, Inc. ("Cardinal IP"), the leading U.S. provider of patent searching,
managed docketing, AI patent drafting, AI amendment drafting, IP consulting,
and IP annuity and renewal payment services, giving GenIP accelerated access
to the US corporate market and a high-credibility distribution channel for its
AI-enabled tools.
Highlights
· The Alliance brings together GenIP's proprietary AI-driven analytics
platform with Cardinal IP's industry leading professional services.
· Cardinal IP is the premier IP services firm in the United States with
deep operational scale and long standing client relationships, selected by the
US Patent and Trademark Office (USPTO) to perform Patent Cooperation Treaty
search services, and serves Fortune 500 corporations, government agencies and
leading law firms.
· The Alliance establishes a reciprocal sale relationship where both
parties sell each others' products and services to their clients. This will
expand the range of services each company can offer, establishing high margin,
recurring service channels for both companies.
· The Board considers this Alliance a material step in broadening
GenIP's commercial footprint, given Cardinal IP's established position across
major US corporate and legal innovation ecosystems.
Market Opportunity
The global IP services market exceeds $25bn annually (World Intellectual
Property Organization), driven by rising patent filings, litigation activity,
and sustained innovation investment.¹ Within this, the AI-enabled IP services
segment is projected to exceed $8bn by 2030, with patent drafting and
analytics among the fastest-growing subsegments.²
This Alliance creates a significant opportunity for GenIP to access the
corporate and enterprise market. Global corporate R&D expenditure reached
a historic high in 2024³ generating continuous and recurring demand for IP
protection, portfolio management, and commercialisation support through the
search, valuation, and analytics services this Alliance is structured to
deliver. Cardinal IP's established Fortune 500 and law firm relationships
provide GenIP with a direct distribution route into this segment at a scale
its existing channels do not reach. GenIP's international network across 25+
countries extends the Alliance's addressable market beyond the United States.
Strategic Rationale
Few IP service providers combine the traditional IP operations at scale
(Cardinal IP) with AI-driven analytics and automation (GenIP). This creates a
differentiated, defensible market position in a sector that is beginning to
adopt AI at scale.
The reciprocal fee structure provides a clear commercial pathway for both
companies to generate incremental revenue from existing client relationships.
For GenIP
Revenue and margin acceleration: Cardinal IP provides a pipeline for
subscription and repeat use AI services
Access to a large client base: GenIP's AI tools gain accelerated distribution
into Cardinal IP's long-standing accounts
Credibility: Cardinal IP's established reputation strengthens GenIP's standing
with corporations, law firms and research institutes
Scalability: Supports GenIP's transition toward a recurring revenue model,
consistent with its platform growth strategy
Taken together, these factors strengthen GenIP's ability to participate in
higher-value segments of the global IP services market using its existing
operating model.
For Cardinal IP
International distribution: Access to GenIP's client network across 25+
countries at no capital cost, extending Cardinal IP's reach beyond its core US
market
Expanded offering: GenIP's commercialisation analytics complement Cardinal
IP's IP protection services across the full innovation lifecycle
New revenue streams: Incremental revenue from AI-assisted analytics at low
marginal cost, without additional headcount
Melissa Cruz, CEO of GenIP, commented:
"This Alliance with Cardinal IP gives GenIP a credible distribution route into
the corporate enterprise segment, the largest and most recurring part of the
global IP services market. The fee structure is commercially grounded, with
fees reaching up to 30% on AI-enabled drafting services, and the performance
incentive built into the agreement ensures both parties are motivated to
convert introductions into revenue. We have designated commercial teams on
both sides and a clear go-to-market approach, and we look forward to adding
value to both organisations and positioning GenIP at the forefront of the
global IP services industry."
Nathan Frederick, Chief Operating Officer, Cardinal Intellectual Property,
commented:
"Cardinal IP is strengthening its global presence through this new strategic
alliance with GenIP. This collaboration allows us to access new international
markets and deliver our top-tier IP services to a broader customer base. By
combining Cardinal's industry-leading expertise with GenIP's innovative reach,
we are set to drive accelerated sales growth and provide a wider array of
services to a global audience."
About Cardinal Intellectual Property
Cardinal IP is the leading intellectual property services firm in the United
States, serving Fortune 500 corporations, major law firms, and government
agencies. Cardinal IP has been selected by the USPTO to perform Patent
Cooperation Treaty search services. Further information:
https://cardinal-ip.com (https://cardinal-ip.com/)
¹ WIPO, World Intellectual Property Indicators, 2023 ² Fortune Business
Insights, AI in Legal Market, 2024 ³ WIPO, Global Innovation Index 2025,
September 2025 ⁴ Parola Analytics, 2024 USPTO Patent Roundup
For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:
GenIP Plc Via Redchurch Communications
Melissa Cruz, CEO
Beaumont Cornish Limited (Nominated Adviser) Tel: +44 (0) 20 7628 3396
Roland Cornish / Asia Szusciak / Andrew Price
AlbR Capital Limited (Broker) Tel: +44 (0)20 7399 9427
Colin Rowbury cr@albrcapital.com (mailto:cr@albrcapital.com)
Jon Belliss Jb@albrcapital.com (mailto:Jb@albrcapital.com)
Redchurch Communications (Financial PR) genip@weareredchurch.com (mailto:genip@weareredchurch.com)
John Casey
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.
Notes to Editors
About GenIP
GenIP is a next-generation business at the intersection of
generative AI and innovation strategy. We empower corporates, venture funds,
and research institutions to evaluate, commercialise, and scale breakthrough
technologies. By combining proprietary GenAI algorithms with expert human
analysis, GenIP delivers decision-grade insights and talent solutions that
accelerate innovation outcomes.
Service Offerings
GenIP operates through two synergistic service lines:
Service Description Value Proposition
Invention Intelligence Product Suite AI-powered market intelligence reports assessing the commercial potential of Enables faster, evidence-based decisions on R&D prioritisation,
emerging technologies investment, and IP strategy
Talent and Executive Search Services Executive search platform using machine learning and NLP to match De-risks scaling by aligning technical vision with proven executive capability
innovation-driven organisations with commercialisation-ready leadership
Together, these services form a unified GenAI-enabled platform for innovation
triage and execution.
Vision & Strategy
GenIP aims to become the global leader in generative AI analytics for
innovation commercialisation. Our strategy is anchored in three growth
pillars:
● Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach
to corporates, VCs, and research institutions, supported by strategic
marketing and digital engagement.
● Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both
service lines-unlocking new use cases and customer segments.
● Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated
market traction to broaden our offering and accelerate growth.
Forward looking statements
Certain statements contained in this announcement constitute forward-looking
statements. When used in this announcement, the words "may", "would", "could",
"will", "intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to the Company,
are intended to identify forward-looking statements. These statements include,
but are not limited to, statements regarding intentions, beliefs or current
expectations concerning, among other things, the Company's results of
operations, financial position, liquidity, prospects, growth, strategies and
expectations of the industry in which the Company operates.
Such statements reflect the Company's current views with respect to future
events and are subject to certain risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements
to materially differ from those described in this announcement Should one or
more of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual results may
differ materially from those described in this announcement as "intended",
"planned", "anticipated", "believed", "proposed", "estimated" or "expected".
For the avoidance of doubt, the contents of the Company's website and any
hyperlinks accessible from the Company's website are not incorporated by
reference into, and do not form part of, this announcement and investors
should not rely on them.
-ENDS-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDUBSORNSUSUAR
Copyright 2019 Regulatory News Service, all rights reserved